No Data
No Data
Trending Industry Today: PHARMARON Leads Losses In CRO Stocks
Trending Industry Today: TIGERMED Leads Gains In CRO Stocks
Trending Industry Today: WUXI BIO Leads Gains In CRO Stocks
PHARMARON: 2024 INTERIM REPORT
HK stocks anomaly | CRO concept stocks continue to rise, hindered by the enactment of the Biosecurity Law, top companies' investment sentiment is expected to marginally improve.
The CRO concept stocks continue to rise. As of the time of publication, Tigermed (03347) rose by 9.28%, to 31.2 Hong Kong dollars; Pharmaron (03759) rose by 4.85%, to 11.24 Hong Kong dollars; and Joinn Laboratories (06127) rose by 4.8%, to 7.64 Hong Kong dollars.
Guosen Securities CXO interim report summary: Integrated leader growth steady, focus on continued recovery of overseas demand.
After experiencing a previous round of adjustments, the current valuation has already fully reflected concerns about future geopolitical uncertainties, with leading revenue and new signings remaining stable. Focus on leading CXOs with a good competitive landscape, efficiency, and cost advantages.
No Data
No Data